Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Interest Coverage Ratio Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | -347.04% |
| 4 | BeOne Medicines | 472.04 Bn | 467.25 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.28 Bn | 115.03 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.66 Bn | 62.66 Bn | - | - |
| 8 | Argenx Se | 56.16 Bn | 50.98 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.56 Bn | 34.55 Bn | 959.66 Mn | 1,378.45% |
| 10 | Lexicon Pharmaceuticals | 920.55 Mn | 749.89 Mn | 20.99 Mn | 97.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 97.32% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | 80.60% |
| Jun 30, 2025 | 101.89% |
| Mar 31, 2025 | 5.57% |
| Dec 31, 2024 | 34.36% |
| Sep 30, 2024 | -190.48% |
| Jun 30, 2024 | -307.45% |
| Mar 31, 2024 | 46.43% |
| Dec 31, 2023 | 71.30% |
| Sep 30, 2023 | 82.02% |
| Jun 30, 2023 | 48.09% |
| Mar 31, 2023 | 91.95% |
| Dec 31, 2022 | 88.97% |
| Sep 30, 2022 | 80.09% |
| Jun 30, 2022 | 88.86% |
| Mar 31, 2022 | -70.33% |
| Dec 31, 2021 | -8,674.88% |
| Sep 30, 2021 | -737.98% |
| Jun 30, 2021 | -743.33% |